biotechstocks
Speaking to the Investing News Network, Kerry Stevenson, host of Making Money Matter, explained why she sold all but three stocks in her portfolio late last year, and what she's doing with her money now. "I actually cashed in the whole portfolio aside from one coal stock ... and two gold stocks," she said on the sidelines of the Rule Symposium. "I've been sitting in cash up until about two and a half weeks ago, when I've come back in with quite big licks on four stocks, and I've still got some cash where I'm looking at some of the small caps." One gold stock Stevenson is "very happy" with is S...
Investing News Network
Artificial intelligence (AI) has emerged as a valuable tool for solving complex societal issues, and although it's a new industry, its impact is already being felt in key areas of the life science sector. AI models in healthcare are quickly advancing beyond basic tasks like medical transcription and administrative streamlining; many systems can now effectively analyze extensive genetic data. By harnessing AI models' ability to identify patterns and make predictions, medical professionals can institute more effective, personalized treatments and develop precision tests to catch diseases earlier...
Investing News Network
These Biotech Stocks Have Been Brilliant in 2022 Thus FarBiotechnology is known to be one of the most volatile sectors in the market, which is why it’s been so interesting to see certain stocks in that area showing lots of relative strength during a volatile first few months of the year. Investors should note that it is especially important to choose carefully when adding exposure in this area of the market, as many of these companies are one FDA approval away from success and failure. A great way to potentially take advantage of the upside that biotech stocks have to offer is by narrowing you...
ValueWalk
Brilliant Biotech Plays to Consider Adding NowWhile the idea of adding exposure to one of the most volatile sectors of the market during a correction might not sound great on paper, the truth is that investors should view the biotech sector as a sleeping giant that could be ready to wake up in the coming weeks. Many of the strongest biotech companies can make for great core holdings in your portfolio thanks to a combination of strong drugs that generate stable cash flows and high upside novel drugs in development that have the potential to become huge winners. Q4 2021 hedge fund letters, confe...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら